The accompanying notes are an integral part of these Consolidated Financial Statements.
Consolidated Balance Sheets, Acc. to IFRS
| Assets in € | Notes No./Page |
31.08.2006 | 31.08.2005 |
| Current assets: | |||
| Liquid funds | 3.9/52 | 2,510,285 | 9,614,529 |
| Marketable securities | 5.5/60 | 7,495,189 | 955,622 |
| Cash and cash equivalents | 10,005,474 | 10,570,151 | |
| Accounts receivable, net of allowances for doubtful accounts of | |||
| € 156,759 and € 155,924 at 31.08.2006 and 31.08.2005, respectively | 3.7/52 | 2.774.928 | 1.553.805 |
| Unbilled revenues | 5.3/59 | 410,649 | 170,404 |
| Tax receivables | 5.4/60 | 125,920 | 178,274 |
| Other current assets and prepaid expenses | 5.4/60 | 105,205 | 152,877 |
| Total current assets | 13,422,176 | 12,625,511 | |
| Non-current assets: | |||
| Intangible assets | 5.1/58 | 109,899 | 101,172 |
| Property and equipment | 5.1/58 | 1,028,960 | 872,586 |
| Deferred tax assets | 6.5/65 | 505,824 | 146,962 |
| Total non-current assets | 1,644,683 | 1,120,720 | |
| Total assets | 15,066,859 | 13,746,231 | |
| Liabilities and shareholders’ equity in € | Notes No./Page |
31.08.2006 | 31.08.2005 |
| Current liabilities: | |||
| Trade accounts payable | 3.11/53 | 1,240,316 | 801,924 |
| Advance payments received | 280,772 | 313,187 | |
| Accrued expenses | 5.7/61 | 1,709,274 | 1,465,386 |
| Deferred income and other current liabilities | 5.8/62 | 305,234 | 831,697 |
| Total current liabilities | 3,535,596 | 3,412,194 | |
| Shareholders’ equity: | |||
| Common stock, stated value € 1, issued: 11,542,764 and 11,542,764, | |||
| outstanding: 11,411,417 and 11,411,417 at 31.08.2006 and 31.08.2005, respectively | 5.6/61 | 11,542,764 | 11,542,764 |
| Additional paid-in capital | 5.6/61 | 17,596,005 | 17,596,005 |
| Reserves for share-based compensation | 17,121 | 9,165 | |
| Treasury stock, 131,347 and 131,347 at 31.08.2006 and 31.08.2005, respectively | 5.6/61 | –200,933 | –200,933 |
| Accumulated deficit | –17,449,040 | –18,640,760 | |
| Changes in shareholders’ equity not affecting net income | 5.6/61 | 25,346 | 27,796 |
| Total shareholders’ equity | 11,531,263 | 10,334,037 | |
| Total liabilities and shareholders’ equity | 15,066,859 | 13,746,231 | |